Lesser Poland Cracovian Heart Failure Registry

Last updated: March 4, 2024
Sponsor: Jagiellonian University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Congestive Heart Failure

Heart Failure

Chest Pain

Treatment

N/A

Clinical Study ID

NCT05746923
1072.6120.349.2022
  • Ages > 18
  • All Genders

Study Summary

The goal of Lesser Poland Cracovian Heart Failure Registry (LECRA-HF) is to expand the knowledge about acute heart failure (AHF) and its long-term prognosis.

The main questions are:

  • assessment of long-term prognosis of AHF and its determinants

  • determination of the optimal AHF treatment methods

  • assessment of indications for invasive coronary arteries diagnostics and revascularization and their long-term effects

  • analysis of the particular HF subtypes (HFimpEF, HFpEF, HFsnEF, HFrEF, HFmrEF)

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • hospitalization due to acute heart failure
  • > 18 years of age

Exclusion

Exclusion Criteria:

  • inability to give informed consent to participate in the registry

Study Design

Total Participants: 2500
Study Start date:
February 15, 2023
Estimated Completion Date:
December 31, 2026

Study Description

LECRA-HF is a registry of patients with acute heart failure (AHF) hospitalized in the Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow, Jagiellonian University Medical College. So far, a small population of patients has been included in similar registries conducted in the Polish population. This did not allow to draw reliable conclusions about this diverse group of patients.

As part of the LECRA-HF registry, a comprehensive analysis of the clinical characteristics of patients is planned, taking into account their medical history, anthropometric measurements, results of electrocardiographic, imaging and laboratory tests, as well as the treatment used during the index hospitalization and after discharge. Their long-term prognosis will also be analyzed. LECRA-HF is a continuous registry, updated annually until 2026.

The data collected in the LECRA-HF will be used to distinguish and describe relatively new subtypes of HF (HFimpEF, HFsnEF) as well as to properly characterize that difficult and very diverse population with a serious long-term prognosis.

Connect with a study center

  • Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow, Jagiellonian University Medical College

    Kraków, 31-202
    Poland

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.